Lupin Limited has informed the Exchange about press release dated 05-Apr-2022 titled Lupin Enters into Licensing Agreement with Alvion to market Cardiometabolic Drugs in the Southeast Asia region.
Lupin Limited has informed the Exchange about press release dated 05-Apr-2022 titled Lupin Enters into Licensing Agreement with Alvion to market Cardiometabolic Drugs in the Southeast Asia region.